HCPLive Network

ACG 2011: Challenging Issues in Ulcerative Colitis Therapy - Adherence and Quality of Life [Podcast]

Raymond Cross, MD, associate professor of medicine and director of the inflammatory bowel disease program at the University of Maryland School of Medicine, describes challenges with adherence to therapy and discusses methods to improve quality of life.




Further Reading
The US Food and Drug Administration has announced the approval of a new combination treatment for hepatitis C virus.
Half of US states are poorly prepared to prevent, detect, and respond to infectious disease outbreaks. That was the main conclusion of a report issued jointly by the Trust for America's Health and the Robert Wood Johnson Foundation.
Predictors have been identified for referral-warranted-retinopathy of prematurity, according to research published online Dec. 18 in JAMA Ophthalmology.
More Reading
The US Food and Drug Administration has announced the approval of a new combination treatment for hepatitis C virus.